Effects of "Parenting in Sweden" on Trust in Social Services
Launched by KAROLINSKA INSTITUTET · Mar 7, 2025
Trial Information
Current as of April 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All parents invited to participate in PiS can take part in the study.
- • Eligibility extends to parents born outside of Sweden who have children aged 0 to 17 years.
- • There are no restrictions regarding the length of time since their migration to Sweden; i.e., participants may have lived in Sweden for decades prior to joining. - - Literacy is not a requirement for participation.
- Exclusion Criteria:
- • Individuals who are unable, physically or not willing, to sign a consent form will not be eligible to participate in the study.
About Karolinska Institutet
Karolinska Institutet is a renowned medical university located in Sweden, recognized for its commitment to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the institution focuses on translating scientific discoveries into effective treatments and therapies, emphasizing patient-centered approaches. With a strong emphasis on collaboration and interdisciplinary research, Karolinska Institutet plays a pivotal role in addressing global health challenges and improving patient outcomes, leveraging its extensive network of experts and state-of-the-art facilities to drive clinical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stockholm, , Sweden
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Related Blog Entries
View all
